Insiders Kymera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
33.62 ^USD	-3.00%		-5.85%	+32.05%

Apr. 22	Oppenheimer Starts Kymera Therapeutics With Outperform Rating, $53 Price Target	MT
Apr. 08	Kymera Therapeutics, Inc Announces Scientific Presentations At the American Association for Cancer Research 2024 Annual Meeting	CI

Kymera Therapeutics, Inc. Appoints Felix J. Baker to the Board	Apr. 01	CI
Kymera Therapeutics Insider Sold Shares Worth $14,912,376, According to a Recent SEC Filing	Mar. 14	MT
Kymera Therapeutics Insider Sold Shares Worth $300,470, According to a Recent SEC Filing	Jan. 24	MT
Kymera Therapeutics Appoints Jeremy Chadwick COO	23-05-22	MT
Kymera Appoints Jeremy Chadwick as Chief Operating Officer	23-05-22	CI
Kymera Therapeutics, Inc. Announces Departure of Elaine Caughey as Chief Business Officer	23-02-27	CI
Insider Sell: Kymera Therapeutics	23-01-17	MT
Kymera Therapeutics, Inc. Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary	23-01-04	CI
Insider Sell: Kymera Therapeutics	22-12-16	MT
Insider Sell: Kymera Therapeutics	22-11-04	MT
Kymera Therapeutics, Inc. Announces Management Changes	22-11-03	CI
Insider Sell: Kymera Therapeutics	22-11-02	MT
Kymera Therapeutics, Inc. Appoints Leigh Morgan to its Board of Directors	22-07-08	CI
Kymera Therapeutics, Inc. Announces Executive Change	22-04-11	CI
Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Directors	22-01-18	CI
Insider Sell: Kymera Therapeutics	22-01-13	MT
Kymera Therapeutics, Inc. Appoints Vijay Sabesan as Senior Vice President, Technical Operations	21-12-06	CI
Insider Sell: Kymera Therapeutics	21-11-03	MT
Insider Sell: Kymera Therapeutics	21-10-12	MT
Kymera Therapeutics : Chief Scientific Officer Chesworth to Depart Next Month -- Shares Drop in Late Hours Trading	21-09-16	MT

No results for this search